Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
8
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Three more people died Thursday after receiving the AstraZeneca vaccine against COVID-19, officials said, raising the number of post-vaccination deaths in the country to five.
A 52-year-old patient at a long-term care hospital in Jeonju, 243 kilometers south of Seoul, died early Thursday morning, nearly two days after being vaccinated, according to North Jeolla Province officials.
The patient had a cardio-cerebrovascular disease and suffered a brain hemorrhage in June.
The second patient, aged 58, died at a long-term care hospital in nearby Buan also early Thursday, less than a day after receiving the vaccine, according to the officials.
The patient's preexisting conditions included a myocardial infarction and diabetes.
"Neither of them showed adverse reactions to the vaccination," a provincial health official said, noting that health authorities will meet with four infectious disease experts in the afternoon to determine any correlation between the deaths and the vaccine.
"For now, it appears unlikely that the deaths were caused by the vaccination," the official added.
In the central city of Daejeon, 164 km south of Seoul, a woman in her 20s died early Thursday after receiving the jab on Tuesday.
The woman was also a patient at a long-term care hospital.
The news follows reports of two deaths on Wednesday, the first since South Korea began a nationwide COVID-19 vaccination program on Friday.
The two men were residents of separate long-term care facilities in Goyang and Pyeongtaek, Gyeonggi Province.
Health authorities have vowed to look closely into the deaths to determine any connection between them and the vaccine, but maintained that no correlation has been found in similar cases worldwide. (Yonhap)
A 52-year-old patient at a long-term care hospital in Jeonju, 243 kilometers south of Seoul, died early Thursday morning, nearly two days after being vaccinated, according to North Jeolla Province officials.
The patient had a cardio-cerebrovascular disease and suffered a brain hemorrhage in June.
The second patient, aged 58, died at a long-term care hospital in nearby Buan also early Thursday, less than a day after receiving the vaccine, according to the officials.
The patient's preexisting conditions included a myocardial infarction and diabetes.
"Neither of them showed adverse reactions to the vaccination," a provincial health official said, noting that health authorities will meet with four infectious disease experts in the afternoon to determine any correlation between the deaths and the vaccine.
"For now, it appears unlikely that the deaths were caused by the vaccination," the official added.
In the central city of Daejeon, 164 km south of Seoul, a woman in her 20s died early Thursday after receiving the jab on Tuesday.
The woman was also a patient at a long-term care hospital.
The news follows reports of two deaths on Wednesday, the first since South Korea began a nationwide COVID-19 vaccination program on Friday.
The two men were residents of separate long-term care facilities in Goyang and Pyeongtaek, Gyeonggi Province.
Health authorities have vowed to look closely into the deaths to determine any connection between them and the vaccine, but maintained that no correlation has been found in similar cases worldwide. (Yonhap)
